Sweden joins germany to only give AZ vaccine to younger then 65 years old;
Astra Zeneca becomes a youth vaccine
The Swedish Public Health Agency does not recommend that Astra Zeneca's vaccine be given to people aged 65 and over.
- There is not enough data documenting protection in the older age groups, says Sören Andersson, unit manager for the Swedish Public Health Agency.
Astra Zeneca is the third covid-19 vaccine to be approved. But it will not be given to people over 65 years of age. Instead, other approved vaccines should primarily be reserved for them.
The reason is that there are not enough data on how Astra Zeneca's vaccine protects the elderly.
- From EMA's point of view, there is not enough data that documents protection in the older age groups, says Sören Andersson, unit manager for the Swedish Public Health Agency, at today's press conference.
Charlotta Bergquist, vaccine coordinator at the Medical Products Agency, says that Astra Zeneca's vaccine has a protective effect of 60 percent in people who have received two doses and are 18 years and up.
- In clinical studies, 64 people have developed covid-19 in the vaccine group against 154 in the placebo group, which means a protective effect of 60 percent.
Can not calculate the effect on those over 55 years
According to Bergquist, it is not possible to calculate the protective effect in people over 55 years of age.
- There are too few cases in the study to be able to calculate a protective effect. On the other hand, we believe that the vaccine also has a protective effect in the elderly based on antibody responses.
From previous flu vaccines, it is known that the protective effect decreases with increasing age.
- But where that limit goes, we can not comment on, she says.
As people over the age of 65 will not receive the vaccine, the Swedish Public Health Agency will review the priority order this week.
- There will be no major revolutionary changes in the order of priority, but a little clearer help to use available vaccines. It is still the case that age has the highest priority, but it is conceivable that healthcare professionals can use the Astra Zeneca vaccine, says Sören Andersson, at the Swedish Public Health Agency.
Astra Zeneca's vaccine is now awaiting approval from the Medical Products Agency before the Swedish population can access it. A product information will soon be available on the Medical Products Agency's website.
Vaccine coordinator Charlotta Bergquist says that the Medical Products Agency monitors adverse reaction reporting and effects at both national and EU level.
- Predominant reactions are related to the injection itself, that they hurt at the injection site, you can feel sick as a result of the immune system being activated.https://www.aftonbladet.se/nyheter/a/WO ... domsvaccin